Accrued Expenses

6 Months Ended

Jun. 30, 2024

Accrued Expenses [Abstract]

Accrued Expenses

(5) Accrued Expenses

Accrued expenses consisted of the following:

	June 30,		December 31,
	2024		2023
Clinical trial costs	$	334,799		276,141
Accrued interest		250,025		—
Incentive and other compensation costs		170,328		1,082,606
Director fees		70,000		60,210
Franchise taxes		3,150		12,160
Other		58,050		13,179
Accrued expenses	$	886,352		1,444,296